HOOKIPA Pharma
HOOKIPA Pharma was a New York- and Vienna-based clinical-stage biopharmaceutical company that developed arenavirus-vector immunotherapies. After selling its infectious-disease and oncology assets, shareholders approved liquidation and the company was dissolved in 2026.
Key facts
| Business Model | Commerce |
|---|---|
| Full Address | 350 Fifth Avenue, Room/Suite 7240 New York, NY 10118 |
| Stock Symbol | HOOK |
| Wellfound ID | hookipa-biotech |